Press release
Impact Of Increasing Prevalence Of Premature Births On The Growth Of The Market Driver: A Major Catalyst in the Evolution of the Survanta Market in 2025
Survanta Market Size
In recent times, the market size for Survanta has seen an CAGR of $XX. Forecasts predict a market growth from $XX million in 2024 to $XX million in 2025, translating to a compound annual growth rate (CAGR) of $XX%. This upward trend in the past can be credited to factors such as the development of neonatal care, a surge in premature births, progression in technologies related to respiratory care, heightened awareness about respiratory illnesses in newborns, and the expansion of healthcare infrastructure in emerging areas.
In the coming years, the Survanta market is projected to witness a compound annual growth rate (CAGR) of $XX%, with the market size reaching an impressive $XX million by 2029. The predicted growth is associated with various factors including an increase in respiratory issues in newborns, progress in surfactant treatment, government efforts to improve neonatal health, growth of neonatal intensive care units (NICUs), and improved healthcare services in developing markets. Significant market trends include advancements in neonatal care, technological breakthroughs, on-the-spot diagnostic services, the use of telemedicine for newborn care, and bespoke medicine.
What Are the Primary Growth Drivers for the Survanta Market?
The future growth of the survanta market is being significantly boosted by the rising rate of premature births. Premature babies, born before the 37th week of pregnancy, often have undeveloped organs and heightened health risks. The surge in premature births is mainly due to factors such as older maternal age, lifestyle choices, a rising rate of chronic conditions, and advancements in fertility treatments. Survanta plays a crucial role in premature births, treating respiratory distress syndrome (RDS), a condition frequently found in premature infants caused by inadequate surfactant production in their lungs. This enhances lung function and minimizes the risk of complications. For example, the US-based government agency, Centers for Disease Control and Prevention, indicated in September 2023 that the percentage of premature live births in England and Wales rose to 7.9% in 2022, from 7.5% in 2021. Therefore, the escalating rate of premature births is fuelling the expansion of the survanta market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20302&type=smp
Who Are the Dominant Companies Influencing Survanta Market Trends?
Major companies operating in the survanta market are AbbVie Ltd.
What Are the Different Segmentations in the Survanta Market?
The survanta market covered in this report is segmented -
1) By Indication: Respiratory Distress Syndrome (RDS); Meconium Aspiration Syndrome (MAS); Bronchopulmonary Dysplasia (BPD); Acute Respiratory Failure; Other Indications
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Public Health Clinics
3) By End-User: Pediatric
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/survanta-global-market-report
Which Region Is at the Forefront of the Survanta Market?
North America was the largest region in the survanta market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the survanta market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Survanta Global Market Report?
- Market Size Analysis: Analyze the survanta Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the survanta Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall survanta market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the survanta market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20302
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact Of Increasing Prevalence Of Premature Births On The Growth Of The Market Driver: A Major Catalyst in the Evolution of the Survanta Market in 2025 here
News-ID: 3875250 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Survanta
Pulmonary Surfactant Market to Reach USD 579 Million by 2034
Introduction
The global Pulmonary Surfactant Market is entering a dynamic growth phase, driven by the increasing prevalence of respiratory distress syndrome (RDS) in premature infants, growing awareness about neonatal care, and rapid innovations in synthetic surfactant formulations. Pulmonary surfactants-critical agents that reduce surface tension within the lungs-are essential for breathing and gas exchange, particularly in newborns with immature lungs.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/76083
Over the past…
Emerging Drivers Influencing The Growth Of The Survanta Market: Rising Prevalenc …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Big Is the Survanta Market Size Expected to Be by 2034?
In recent times, the market size of Survanta has witnessed a (HCAGR) of XX. Projected growth indicates that the industry will expand from $XX million in 2024 to $XX million in 2025, demonstrating a compound annual growth rate (CAGR) of…
Survanta Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
Get 20% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!
How Are the key drivers contributing to the expansion of the survanta market?
The increasing prevalence of premature births is significantly contributing to the growth of the Survanta market in the future. Premature births occur when a baby is born before 37 weeks of pregnancy, leading to underdeveloped organs and increased health…
Efficiency To Be Driven By Digitization In The Respiratory Distress Syndrome Mar …
Respiratory distress syndrome is a lung disorder of neonates caused by a deficiency of surfactants. It affects premature infants with symptoms of collapsed lungs and breathing difficulty. Other symptoms include nasal flaring, use of accessory muscles and grunting respirations. Respiratory distress syndrome is a rare disorder and it affects only a few percent's of the population.
The risk of respiratory distress syndrome increases with prematurity of the infant and it is…
Respiratory Distress Syndrome Market Analysis and Forecast 2018-2026 | ONY Biote …
"The Latest Research Report Respiratory Distress Syndrome Market - Global Industry Trend Analysis 2013 to 2017 and Forecast 2018-2026 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Respiratory distress syndrome is a lung disorder of neonates caused by a deficiency of surfactants. It affects premature infants with symptoms of collapsed lungs and breathing difficulty. Other symptoms include nasal flaring, use of accessory…
Treating Infant Respiratory Distress Disorders with Pulmonary Surfactants
FOR IMMEDIATE RELEASE
New York, U.S.:Infants who experience respiratory distress disorders are commonly treated with pulmonary surfactants. Respiratory distress syndrome (RDS) is a condition in which the lungs are not fully developed and the infant has trouble breathing on his or her own. This is due to insufficient amounts of surfactant, which is a naturally occurring substance that coats the lungs and allows them to function properly. Infants who are born…
